Cammà C - Search Results

1

A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma.

Cabibbo G, Petta S, Barbàra M, Missale G, Virdone R, Caturelli E, Piscaglia F, Morisco F, Colecchia A, Farinati F, Giannini E, Trevisani F, Craxì A, Colombo M, Cammà C; ITA.LI.CA study group. Cabibbo G, et al. Among authors: camma c. Liver Int. 2017 Aug;37(8):1157-1166. doi: 10.1111/liv.13357. Epub 2017 Feb 1. Liver Int. 2017. PMID: 28061016

2

Preoperative and postoperative radiotherapy and survival in colorectal cancer.

Cammà C, Fiorica F, Craxì A, Cottone M. Cammà C, et al. Lancet. 2002 Mar 23;359(9311):1068; author reply 1069. doi: 10.1016/S0140-6736(02)08077-7. Lancet. 2002. PMID: 11937213 No abstract available.

3

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

Cammà C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxì A, Cottone M. Cammà C, et al. Radiology. 2002 Jul;224(1):47-54. doi: 10.1148/radiol.2241011262. Radiology. 2002. PMID: 12091661 Review.

4

When and how to treat acute hepatitis C?

Licata A, Di Bona D, Schepis F, Shahied L, Craxí A, Cammà C. Licata A, et al. Among authors: camma c. J Hepatol. 2003 Dec;39(6):1056-62. doi: 10.1016/s0168-8278(03)00461-6. J Hepatol. 2003. PMID: 14642626

5

Interferon-alpha for HBeAg-positive chronic hepatitis B.

Craxì A, Di Bona D, Cammà C. Craxì A, et al. Among authors: camma c. J Hepatol. 2003;39 Suppl 1:S99-105. doi: 10.1016/s0168-8278(03)00154-5. J Hepatol. 2003. PMID: 14708686 Review. No abstract available.

6

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data.

Cammà C, Di Bona D, Schepis F, Heathcote EJ, Zeuzem S, Pockros PJ, Marcellin P, Balart L, Alberti A, Craxì A. Cammà C, et al. Hepatology. 2004 Feb;39(2):333-42. doi: 10.1002/hep.20073. Hepatology. 2004. PMID: 14767986

7

The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach.

Cammà C, Di Bona D, Craxì A. Cammà C, et al. Curr Pharm Des. 2004;10(17):2123-30. doi: 10.2174/1381612043384321. Curr Pharm Des. 2004. PMID: 15279551 Review.

8

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial.

Bruno S, Cammà C, Di Marco V, Rumi M, Vinci M, Camozzi M, Rebucci C, Di Bona D, Colombo M, Craxì A, Mondelli MU, Pinzello G. Bruno S, et al. Among authors: camma c. J Hepatol. 2004 Sep;41(3):474-81. doi: 10.1016/j.jhep.2004.05.012. J Hepatol. 2004. PMID: 15336451 Clinical Trial.

9

Treatment of hepatitis C: critical appraisal of the evidence.

Cammà C, Licata A, Cabibbo G, Latteri F, Craxì A. Cammà C, et al. Expert Opin Pharmacother. 2005 Mar;6(3):399-408. doi: 10.1517/14656566.6.3.399. Expert Opin Pharmacother. 2005. PMID: 15794731 Review.

10

Prevention of hepatocellular carcinoma.

Craxì A, Cammà C. Craxì A, et al. Among authors: camma c. Clin Liver Dis. 2005 May;9(2):329-46, viii. doi: 10.1016/j.cld.2004.12.008. Clin Liver Dis. 2005. PMID: 15831277 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

421 results

Search Page

Filters